Back to Top
Go Back
Journal Photo for Psychological Medicine
Peer reviewed only Open Access

Psychological Medicine (PM)

Publisher : Cambridge University Press
Psychiatry Psychology
Claim Your Journal Get PRC Visit Website
e-ISSN 1469-8978
p-ISSN 0033-2917
Issue Frequency Yearly
Est. Year 1971
Mobile 441223326050
Country United Kingdom
Language English
APC YES
Impact Factor Assignee Google Scholar
Email psychmed@cambridge.org

Journal Descriptions

Psychological Medicine is a leading international journal in the fields of psychiatry, clinical psychology and the related basic sciences. The journal includes original articles reporting key research being undertaken worldwide, together with literature reviews and shorter editorials by distinguished scholars.

Psychological Medicine (PM) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Psychiatry, Psychology , Online or Print , Yearly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0033-2917, E-ISSN: 1469-8978, Established: 1971,
  • Does Not Provide Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of PM

Body mass index in the middle-aged offspring of parents with severe mental illness
Peter B Jones June, 2023
Background People with severe mental illness (SMI) have an elevated risk of obesity but the causes and mechanisms are unclear. We explored the familial association between parental SMI and ...
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and c...
Peter B Jones September, 2021
Background First episode psychosis (FEP) patients who use cannabis experience more frequent psychotic and euphoric intoxication experiences compared to controls. It is not clear whether thi...
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study
Peter B Jones June, 2021
Background Daily use of high-potency cannabis has been reported to carry a high risk for developing a psychotic disorder. However, the evidence is mixed on whether any pattern of cannabis u...
Breaking the web: life beyond the at-risk mental state for psychosis
Peter B Jones September, 2019
Psychiatry's most recent foray into the area of risk and prevention has been spear-headed by work on at-risk mental states for psychotic disorders. Twenty-five years' research and clinical a...
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study
Peter B Jones April, 2020
Background The ‘jumping to conclusions’ (JTC) bias is associated with both psychosis and general cognition but their relationship is unclear. In this study, we set out to clarify the re...
Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis
Peter B Jones July, 2020
Background To determine the baseline individual characteristics that predicted symptom recovery and functional recovery at 10-years following the first episode of psychosis. Methods AES...
Predicting first-episode psychosis patients who will never relapse over 10 years
Peter B Jones October, 2019
Background Although relapse in psychosis is common, a small proportion of patients will not relapse in the long term. We examined the proportion and predictors of patients who never relapse...
Identifying key targets for interventions to improve psychological wellbeing: replicable results from four UK cohorts
Peter B Jones October, 2019
Background An increasing importance is being placed on mental health and wellbeing at individual and population levels. While there are several interventions that have been proposed to impr...
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Peter B Jones September, 2019
Background Peripheral low-grade inflammation in depression is increasingly seen as a therapeutic target. We aimed to establish the prevalence of low-grade inflammation in depression, using ...
Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
Peter B Jones September, 2019
Background Neuropsychological investigations can help untangle the aetiological and phenomenological heterogeneity of schizophrenia but have scarcely been employed in the context of treatme...